The authors of this study aimed to compare the quality of life (QoL) after Transapical transcatheter aortic valve implantation (TA-TAVR) versus surgical aortic valve replacement (SAVR). They used the QoL data of 875 TA-TAVR patients from the PARTNER nonrandomized continued acces registry and compared this with the smaller randomized group of TA-TAVI and SAVR patients. They found that despite more experience in this continued access population, QoL was similar to randomized TA-TAVR patients and SAVR patients.